Small molecule somatostatin receptor subtype 4 (sst4) agonists are novel anti-inflammatory and analgesic drug candidates
Éva Szőke(University of Pecs), Zsuzsanna Helyes(Hungarian Research Network), Mónika Bálint(University of Pecs), T. Szúts, Csaba Hetényi(University of Pecs), Krisztián Elekes(Institute of Pharmacology), Erika Pintér(Centre for Drug Research and Development), László Őrfi, Janós Szolcsányi(University of Pecs), Gÿorgý Kéri(Semmelweis University), Adrienn Markovics(Rush University Medical Center), Sándor Zoltán(Gedeon Richter (Hungary)), Gábor Pozsgai(American Pharmacists Association)
Cited by 15
Related Papers
Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
|Neurobiology of Disease|2011|178
Herbal remedies of Solidago—correlation of phytochemical characteristics and antioxidative properties
|Journal of Pharmaceutical and Biomedical Analysis|2003|152
In vitro antioxidant properties of Helichrysum arenarium (L.) Moench
|Journal of Ethnopharmacology|2000|116
The in vitro effect of Helichrysi flos on microsomal lipid peroxidation
|Journal of Ethnopharmacology|2001|109
Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line
|European Journal of Pharmacology|2009|104